Bacterial pathogen Porphyromonas gingivalis may contribute to Alzheimer's disease: Study
Cortexyme, Inc., a privately held, clinical-stage pharmaceutical company developing therapeutics to alter the course of Alzheimer's disease (AD) and other degenerative disorders, today announced publication of a foundational ...
Jan 23, 2019
2
2084